Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07193875 · ClinicalTrials.gov registry record · Phase 4
Efavirenz (EFV) Intensification
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT07193875 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 7 participants.
The verdict
NCT07193875, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to see if Efavirenz (EFV) intensification to a baseline combination antiretroviral regimen (cART) can help reduce the size of the latent reservoir in people living with HIV (PLWH). The main questions this study aims to address are: 1. is the addition of EFV to a cART regimen safe and well tolerated? 2. Is there a reduction in the blood and tissue HIV reservoir after intensification? Researchers will compare each participants reservoir size prior to and post EFV intensification.
Interventions
- DRUG Efavirenz 600mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-02-09 |
| Est. Completion | 2024-12-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07193875
The ClinicalTrials.gov registry entry for NCT07193875 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Efavirenz 600mg is the first listed.
NCT07193875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07193875 about?
NCT07193875 is a clinical study titled "Efavirenz (EFV) Intensification". The goal of this clinical trial is to see if Efavirenz (EFV) intensification to a baseline combination antiretroviral regimen (cART) can help reduce the size of the latent reservoir in people living with HIV (PLWH). The main questions this study aims to address are: 1. is the addition of EFV to a c...
What is the current status of trial NCT07193875?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2023-02-09. Estimated completion is 2024-12-16.
What interventions are being tested in trial NCT07193875?
The interventions under investigation include: Efavirenz 600mg (DRUG).
Who is sponsoring clinical trial NCT07193875?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.